PLOD2 and neoplasm: DeLong’s test showed that PLOD1 was superior to PLOD2 in predicting tumor and normal outcomes, but the test was not statistically significant (p = 0.148); PLOD1 was significantly superior to PLOD3 (p ≤ 0.01).